Carroll Jill

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Carroll Jill's trades of Avalyn Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-01 2026-05-01
B Purchase
19,977 -9.8%
143.51
US$3,200,752 		19,977 -9.8% 143.51 US$3,200,752
2024-03-25 2024-03-21
US Arcellx Inc (ACLX)
S Sale
90,033 +4.9%
39.65
US$2,710,384 		90,033 +4.9% 39.65 US$2,710,384
2023-12-18 2023-12-14
US Arcellx Inc (ACLX)
S Sale
29,546 -25.7%
243.11
US$753,611 		29,546 -25.7% 243.11 US$753,611
2023-06-02 2023-06-01
US Arcellx Inc (ACLX)
S Sale
25,556 -1.0%
44.35
US$1,133,317 		25,556 -1.0% 44.35 US$1,133,317
2023-06-02 2023-05-31
US Arcellx Inc (ACLX)
S Sale
315,164 -11.1%
41.50
US$13,079,306 		315,164 -11.1% 41.50 US$13,079,306
2023-05-15 2023-05-11
US Arcellx Inc (ACLX)
S Sale
6,485 -0.2%
46.15
US$299,283 		6,485 -0.2% 46.15 US$299,283
2023-05-15 2023-05-11
US Arcellx Inc (ACLX)
S Sale
631,932 -18.2%
45.00
US$28,436,940 		631,932 -18.2% 45.00 US$28,436,940
2022-02-09 2022-02-08
US Arcellx Inc (ACLX)
B Purchase
1,600,000 +369.3%
15.00
US$24,000,000 		1,600,000 +369.3% 15.00 US$24,000,000
2022-02-09 2022-02-08
US Arcellx Inc (ACLX)
B Purchase
66,667 +2.0%
15.00
US$1,000,005 		66,667 +2.0% 15.00 US$1,000,005
2020-07-21 2020-07-21
B Purchase
361,111 +19.1%
18.00
US$6,499,998 		361,111 +19.1% 18.00 US$6,499,998